Much remains to be discovered about Lupus. Not just disease mechanisms and new treatments, but also a better understanding of what it means to live with lupus, the day to day issues faced by patients and their relatives, the impact on social and psychological functioning, … To help people living with lupus bring their life experience to the table, LUPUS EUROPE created Patient panels, by and For people with lupus. The panels bring together 10-15 persons living with lupus from all over Europe to discuss topics of interest. the discussions are animated by People living with lupus themselves, creating a unique atmosphere in the group, and allowing to speak in full confidence, without the fear of the “white blouse”, or the impression that “there must be a correct answer”. Participants can simply be themselves and speak their voice…

3 main patient panels have taken place so far:

Patient panel I on treatment

In  November 2014, 10 Lupus affected persons from 7 countries shared their experience about “treatment”, with the view to help improve the quality of life of people living with lupus. The Panel Brought new understanding of treatment, which participants defined as “any product or activity that aims at improving the person with lupus’ quality of life” and resulted in the issuance of 3 letters addressed respectively to People living with lupus, patients organizations, and the medical community, addressing how they each can help in this area. A full report of  this panel can be found here.

Patient panel II on the burden of living with lupus

In March  2016 , a new panel aimed at further exploring the burden of living with lupus, and to dive into the burden of treatment day after day. One of its objective was to understand the journey with the disease, how the Patient Engagement model used in Health psychology applies to people living with lupus, and the consequences for Patient organisations. The model was validated and its implications for patient organisations, and how they need to address differently patients based on where they are in their journey with lupus are significant. A complete report on this patient panel can be found here.

This panel also resulted in a publication by D. Mazzoni in the magazine Muskulo-skeletal care, which you can download here .

A specific session was dedicated to Clinical trials, seeking to understand what would cause patients to join or not a Clinical trial, and too stay committed till the end.

 

Patient panel III on Youth

In May 2018, our 3rd patient panel was organised on the theme of youth. 10 Lupus affected young people, aged 18 to 26, from all over Europe shared their experience of living with lupus. The agenda was focused on the topics of interest and issues they identified themselves ahead of the Friday to Sunday gathering.  While they considered taking pills every day as a key problem, they preferred to focus on the collective issues of being understood by friends and family and having to live with limitations. A big “Wow” was the feeling of guilt expressed by several female participants (guilt of imposing limits to their partners, guilt of not being able to do as much as others, …). This guilt seems to be a very important underlying dimension of their social and affective life, which is likely much misunderstood by doctors and patient organizations. Young people with lupus remain fundamentally more positive on their life with lupus than the average patients. Their messages to other young people with lupus are reassurance, and positivism, and while they perceive lupus as being “all over their lives”, they want to make sure they are not ruled by it, and want to have no obligations relating to it… On the medical front, when we probed what would drive them to consider joining a clinical trial, clear first media is their lupus doctor, second are national lupus groups and LUPUS EUROPE. A full report of this panel can be downloaded here.

 

LUPUS EUROPE intends to continue running patient panels, so stay tuned on this page, where more information will be available as we progress 🙂

Live Facebook Feed

Comments Box SVG iconsUsed for the like, share, comment, and reaction icons

We are very proud to share that LupusGPT has now been published in The Lancet Rheumatology, one of the world’s leading medical journals in rheumatology.

For us, this is not only about a publication. It is about what LupusGPT stands for.

LupusGPT is free. It is patient-led. And it was built to help people living with lupus find reliable, accessible information in almost any language.

It began with a simple but important question: what could become possible if patients, clinicians, and digital experts truly worked together from the start?

That question was first opened up in a fishbowl discussion at the European Lupus Meeting 2024 on how the lupus community could get the best, but not the worst, out of AI. From there, LupusGPT was shaped through the care, intelligence, and effort of many people: volunteers, patient testers, clinicians testing across languages, people who gave feedback, and people already helping us share it with patients in clinics, organisations, and communities.

This publication matters because it shows that patient-led innovation belongs in the scientific world too. It shows that when patient voice is not added at the end, but built in from the start, something real can grow.

A heartfelt thank you to all authors: Zoe Karakikla-Mitsakou, Alain Cornet, Jeanette Andersen, Sarah Dyball, Cristiana Sieiro Santos, Daniel Guimarães de Oliveira, and Laurent Arnaud. Special thanks also to Daniel Guimarães de Oliveira for the thought, care, and belief he brought to this work, and to Professor Laurent Arnaud for his outstanding support, steadiness, and guidance.

And above all, thank you to everyone in the Lupus Europe community who keeps showing us why this matters.

LupusGPT. Free. Multilingual. Patient-led. And now part of the scientific record.

doi.org/10.1016/S2665-9913(25)00370-4

Read it for free now! You only need to register (registration is completely free and takes 1')
... See MoreSee Less

We are very proud to

🚨 Today is #WORDDAY2026! Which stands for WOrld Young Rheumatic Disease Day.

🌍 Through this global event, we can spread the word that children and young people get rheumatic diseases like lupus, too.

‼️ It is estimated that around 15-20% of #lupus patients are children, although it is rare that a child develops lupus before 5 years of age.

As with adult patients, the cause of lupus remains unknown, and there is a great choice of treatments to keep the disease under control.

🔴 On average, it takes nearly 6 years for people with lupus to be diagnosed. This delay in diagnosis, and therefore in treatment, can have an impact on the prognosis and quality of life of patients; this includes kids.

😰 The moment your child gets a diagnosis might be overwhelming for you. This feeling of overwhelm can and does go away with time and with access to the right information.

👉 Remember: it is impossible to learn everything about #lupus overnight! Your child's doctor is the best source of information.

Apart from pharmacological treatment, other non-pharmacological measures can also help in lupus management.

📷 Take a look at the images we are sharing today to learn about these non-pharmacological measures and share them with your community to help us raise awareness.

🐺 Lupus can seem scary at first. Remember that you are not alone and that you are going to do a great job!

Turn to your lupus association for support.

🤗 There are many organisations across Europe that can help you and your child cope with the disease.

More information on #SLE in children at #Lupus100: f.mtr.cool/oklkpqamyu

For more information on WORD Day, you can visit World Young Rheumatic Diseases Day - WORD Day
... See MoreSee Less

Image attachment
Image attachment
Image attachment
Image attachment
Image attachment

🔴 Tomorrow is #WORDDAY2026!

🦋 And we will be sharing tips and information on how #lupus can affect children.

Help us raise awareness, which is key for an early diagnosis & a quick referral to a specialised paediatric rheumatologist.

Share our posts and follow the World Young Rheumatic Diseases Day - WORD Day campaign.

More information on lupus in children at #Lupus100 (19 languages):

f.mtr.cool/hnfukbkwdf
... See MoreSee Less

🔴 Tomorrow is #WO

Watch this Lupus Europe Webinar on the European Lupus Meeting (ELM) 2026, As Viewed by Lupus Europe's PAN Members & Volunteers!

... See MoreSee Less

0 CommentsComment on Facebook